Medications

US approves Sanofi, Regeneron arthritis drug

US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the chronic inflammatory condition, rheumatoid arthritis.

Medications

Study: Side effects emerge after approval for many US drugs

Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found.

Cardiology

Risk of heart disease associated with NSAIDs

Dear Mayo Clinic: Is it true that taking prescription-strength nonsteroidal anti-inflammatory drugs, or NSAIDs, can increase my risk of heart disease? How much is too much, and should I be concerned about regularly taking ...

Arthritis & Rheumatism

Study reveals enormous advances for rheumatoid arthritis patients

People living with Rheumatoid Arthritis have experienced significant improvements in their daily lives which is probably down to early and more aggressive treatment of the disease, according to new research from The Universities ...

Medications

Overcoming Opioids: The quest for less addictive drugs

Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ...

page 11 from 24